- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Alignment Healthcare lowers 2026 outlook as it navigates cost headwinds | 1 | FierceHealthcare | ||
| Fr | Piper Sandler cuts Alignment Healthcare stock price target on weak guidance | 1 | Investing.com | ||
| ALIGNMENT HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| Fr | Piper Sandler senkt Kursziel für Alignment Healthcare nach schwachem Ausblick drastisch | 2 | Investing.com Deutsch | ||
| Do | Alignment Healthcare Q3 2026 Earnings Call Transcript | 1 | Benzinga.com | ||
| Do | Alignment Healthcare Reports $8 Million Loss As Medicare Costs Linger | 3 | Forbes | ||
| Do | Alignment Healthcare GAAP EPS of -$0.04 in-line, revenue of $1.36B beats by $50M | 4 | Seeking Alpha | ||
| Do | Alignment Healthcare Reports Third Quarter 2026 Results, Updates Full-Year Outlook | 1 | GlobeNewswire (USA) | ||
| Do | Alignment Healthcare, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Mi | Needham initiates Alignment Healthcare stock rating at Hold | 1 | Investing.com | ||
| 22.10. | Alignment Healthcare USA, LLC: Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors | 2 | GlobeNewswire (USA) | ||
| 21.10. | Alignment Healthcare USA, LLC: Alignment Health Expands Medicare Advantage Plan to Nye County for 2027 | 1 | GlobeNewswire (USA) | ||
| 19.10. | Alignment Healthcare USA, LLC: Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California Seniors | 1 | GlobeNewswire (USA) | ||
| 15.10. | Alignment Healthcare USA, LLC: Alignment Health Expands Medicare Advantage Coverage to San Antonio for 2027 | 1 | GlobeNewswire (USA) | ||
| 12.10. | Alignment Healthcare bounces back 7% after sharp prior-session drop | 1 | Seeking Alpha | ||
| 12.10. | Alignment Healthcare sues CMS over its 2027 Medicare Advantage star ratings | 1 | FierceHealthcare | ||
| 12.10. | Alignment Healthcare USA, LLC: Alignment Health Launches New Medicare Advantage Plan Designed for Asian American Seniors in Los Angeles and Orange Counties | 1 | GlobeNewswire (USA) | ||
| 12.10. | TD Cowen senkt Kursziel für Alignment Healthcare wegen EBITDA-Sorgen | 2 | Investing.com Deutsch | ||
| 12.10. | TD Cowen cuts Alignment Healthcare stock price target on EBITDA concerns | 1 | Investing.com | ||
| 12.10. | UBS senkt Kursziel für Alignment Healthcare wegen Auslastungsdrucks drastisch | 1 | Investing.com Deutsch | ||
| 12.10. | UBS cuts Alignment Healthcare stock price target on utilization woes | 1 | Investing.com |
1 2 3 4 Weiter >>
79 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 7,670 | -0,60 % | Piper Sandler raises Teladoc stock price target on BetterHelp growth | ||
| HIMS & HERS HEALTH | 23,260 | +3,19 % | Eli Lilly hängt Novo Nordisk und Hims & Hers ab: Warum die Abnehmspritzen-Aktien auseinanderlaufen | ||
| SERNOVA BIOTHERAPEUTICS | 0,075 | +10,36 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| CERENOME | 1,430 | +0,70 % | Cerenome completes enrollment in glioblastoma drug trial | ||
| ATOSSA THERAPEUTICS | 2,040 | +0,99 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 17,000 | +1,80 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,353 | -0,03 % | Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India | CDSCO Clearance and Commercial Launch in India Anticipated Before Year-End 2026Study Demonstrated 97.3% Sensitivity and 96.0% SpecificityConsistent Performance Across Three Test BatchesIntegrated Mobile... ► Artikel lesen | |
| QUIDELORTHO | 11,630 | -7,18 % | Quidel Q3 2026 Earnings Preview | ||
| VERU | 2,160 | 0,00 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 6,040 | -1,31 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 3,840 | -0,52 % | Clover Health im Aufwind: Needham startet Coverage mit "Buy" und Kursziel von 6 Dollar | ||
| SENSEONICS | 7,900 | -1,86 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| NANO-X IMAGING | 0,302 | +0,03 % | NANO-X IMAGING LTD: TCT 2026 Clinical Data Reveals 84% Reporting Gap in Aortic Valve Calcification, Highlighting the Potential of Nanox.AI's AVC Solution | ||
| TEMPEST THERAPEUTICS | 0,472 | +0,06 % | Tempest Therapeutics, Inc. - 8-K, Current Report |
ALIGNMENT HEALTHCARE INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 6,980 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALIGNMENT HEALTHCARE INC finden Sie auf Wallstreet Online.